Use of thrombopoietin receptor agonists in adults with immune thrombocytopenia: a systematic review and Central European expert consensus

There are currently three thrombopoietin receptor agonists (TPO-RAs) approved in Europe for treating patients with immune thrombocytopenia (ITP): romiplostim (Nplate®), eltrombopag (Revolade®), and avatrombopag (Doptelet®). However, comparative clinical data between these TPO-RAs are limited. Theref...

Descripción completa

Detalles Bibliográficos
Autores principales: Pulanić, Dražen, Bátorová, Angelika, Bodó, Imre, Červinek, Libor, Ionita, Ioana, Lissitchkov, Toshko, Melikyan, Anahit, Podolak-Dawidziak, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951167/
https://www.ncbi.nlm.nih.gov/pubmed/36826482
http://dx.doi.org/10.1007/s00277-023-05114-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951167/
https://www.ncbi.nlm.nih.gov/pubmed/36826482
http://dx.doi.org/10.1007/s00277-023-05114-8

Ejemplares similares